Navigation Links
Valeant Pharmaceuticals Announces Publication of Efinaconazole Phase III Results
Date:11/26/2012

MONTREAL, Nov. 26, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that the Journal of the American Academy of Dermatology has published the positive results from our two pivotal, international,  multicenter, randomized, double-blind, vehicle-controlled studies that were conducted in 1,655 subjects with onychomycosis. Onychomycosis is a common nail infection caused predominantly by dermatophyte fungi, resulting in nail destruction and deformity. The only approved topical treatments are lacquers with very limited efficacy. Oral treatments, while more efficacious, are limited by drug interactions and numerous safety concerns including the potential for acute liver injury. Valeant investigated the safety and efficacy of efinaconazole 10% topical solution (efinaconazole), the first triazole antifungal agent developed for distal lateral subungual onychomycosis (DLSO).

The study's primary endpoint was stringently defined as the complete cure rate at Week 52, which means that the target nail showed no clinical involvement and no evidence of fungus present by both KOH testing and a negative fungal culture. In Study 1, 17.8% of subjects treated with efinaconazole were completely cured, as compared to only 3.3% of subjects treated with vehicle and in Study 2, 15.2% of subjects treated with efinaconazole were completely cured, as compared to only 5.5% of subjects treated with vehicle. Using the secondary endpoint of complete or almost complete cure, defined as < 5% clinical involvement and 100% mycologic cure, the success rates for efinaconazole increased to 26.4% and 23.4%, respectively.  The adverse events that were reported were generally mild and transient and were similar between subjects treated with efinaconazole solution 10% and vehicle.

"We are pleased to share the positive resu
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... (Prime), a thought leader in pharmacy benefit management, has ... 2011 Transparency in Pharmaceutical Purchasing Standards(SM) (TIPPS) certification from ... year that Prime has received this certification. ... (PBMs) that have agreed to provide pharmacy cost information ...
... Oct. 19 Ingenuity® Systems, the leading provider ... TransMed Systems, a translational medicine software and services ... and XB Bio-Integration Suite (XB-BIS).  Researchers can now ... managed and statistically analyzed by XB-BIS, directly into ...
Cached Medicine Technology:Prime Therapeutics Receives 2011 TIPPS Certification 2Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research 2
(Date:4/18/2014)... new medical-testing device is being prepped to enter ... improve diagnosis of certain diseases in remote areas, ... series of investigations aboard the International Space Station ... the space-tested concept of capillary flow to diagnose ... David Kelso, Ph.D., a researcher at Northwestern University ...
(Date:4/18/2014)... Harvard neuroscientists have made a discovery that turns 160 ... electrical insulating material long known to be essential for ... nerve cells, is not as ubiquitous as thought, according ... of the Harvard Stem Cell Institute (HSCI) and the ... collaboration with Professor Jeff Lichtman, of Harvard,s Department of ...
(Date:4/18/2014)... it make you feel? According to psychologists, remembering the ... how sad you were or how embarrassed you felt, ... stop thinking about it. , When these negative ... memories, rather than how you felt, is a relatively ... of these memories, a new study suggests. , Researchers ...
(Date:4/18/2014)... a brain-related discovery that could revolutionize doctors, perception ... opens up the possibility that environmental and/or genetic ... activity that the researchers have identified as helping ... Neuroscience has just published a paper about ... of psychology and his doctoral student John Gaspar, ...
(Date:4/18/2014)... . A ... A team led by Ludwik Leibler from the Laboratoire ... Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits Paris ... principle of adhesion by aqueous solutions of nanoparticles can ... tissues. This easy-to-use gluing method has been tested on ...
Breaking Medicine News(10 mins):Health News:Space-tested fluid flow concept advances infectious disease diagnoses 2Health News:Space-tested fluid flow concept advances infectious disease diagnoses 3Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:Scientists discover brain's anti-distraction system 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3
... Savvy Mom TV ... industry, for expecting, new and seasoned parents. , ... (PRWEB) April 15, 2010 -- Ingrid Prueher, Founder of Savvy Mom on ... resource from home for expecting, new or seasoned parents. , , , , ,This educational, ...
... ... self-contained, portable, maximum output growing system for medical marijuana. The Big Bud product line ... ... Irvine, CA based agriculture solutions provider GrowOp Technology Ltd, partners with iGrow, the San ...
... ... on line, directly from the distributor. , ... (PRWEB) April 15, 2010 -- Arsa Imports of ... that play a vital role in Mexican culture, demonstrate that their most innovative items ...
... IL - A study in the April 15 issue of the ... video game before bedtime has only a mild effect on the ... a stimulating video game it took adolescents a median of 7.5 ... three minutes it took them to fall asleep after passively watching ...
... ... subjects found that the decline in neurological function of the peripheral nervous system attributed ... if these factors are within the normal range. , ... (Vocus) April 14, 2010 -- New ...
... ... multiple sclerosis found a lower incidence of new brain lesions in patients taking the cholesterol-lowering ... ... UCSF-led study examining the impact of statins on the progression of multiple sclerosis found a ...
Cached Medicine News:Health News:Ingrid Prueher, Founder of Savvy Mom on Call Launches Savvy Mom TV, An Educational, Live, Free and Interactive Online Show 2Health News:The Medical Marijuana Industry Finds an Outside-the-Box Solution, "Inside the Box" With GrowOp Technology 2Health News:The Medical Marijuana Industry Finds an Outside-the-Box Solution, "Inside the Box" With GrowOp Technology 3Health News:Arsa Offers High Quality Supplements, Cosmetics and Magic Scents from Mexico for Less Than $10 2Health News:Playing a video game before bedtime has only a mild effect on adolescent sleep 2Health News:Playing a video game before bedtime has only a mild effect on adolescent sleep 3Health News:New UCSF Studies Reveal that Age-Related Nerve Decline is Associated with Inflammation and Differs by Gender 2Health News:New UCSF Studies Reveal that Age-Related Nerve Decline is Associated with Inflammation and Differs by Gender 3Health News:New UCSF Studies Reveal that Age-Related Nerve Decline is Associated with Inflammation and Differs by Gender 4Health News:Statins May Slow Progression of Multiple Sclerosis, New Study Finds 2Health News:Statins May Slow Progression of Multiple Sclerosis, New Study Finds 3Health News:Statins May Slow Progression of Multiple Sclerosis, New Study Finds 4
This is a reduced form of the 100 Hue test and L'Anthony New Color Test. The 40 Hue test is obviously quicker to administer. It provides extensive chromatic sensitivity and gives a quantitative score...
... Farnsworth 100 Hue Test comes boxed in clear ... the potential for test disruption by holding ... Hue test from Richmond Products includes 93 color ... durable laminated score template for copying, a supply ...
... Strep A test is as easy as 1-2-3: ... results. Increase patient satisfaction with rapid information before ... your patient immediately with the appropriate therapy; no ... Use: ,The NOW® Strep A Test is a ...
Single Use Loading Units (SULU's) Knifeless for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
Medicine Products: